Free Access
Med Sci (Paris)
Volume 30, Number 4, Avril 2014
Page(s) 345 - 347
Section Nouvelles
Published online 05 May 2014
  1. Adams D, Lozeron P, Theaudin M, et al. Regional difference and similarity of familial amyloidosis with polyneuropathy in France. Amyloid 2012 ; 19 Suppl 1 : 61–64. [CrossRef] [Google Scholar]
  2. Adams D, Samuel D, Goulon-Goeau C, et al. The course, prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000 ; 123 (Pt 7) : 1495–1504. [CrossRef] [PubMed] [Google Scholar]
  3. Wilczek HE, Larsson M, Ericzon BG, Fapwtr. Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR). Amyloid 2011 ; 18 Suppl 1 : 193–195. [CrossRef] [PubMed] [Google Scholar]
  4. Yamashita T, Ando Y, Okamoto S, et al. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. Neurology 2012 ; 78 : 637–643. [CrossRef] [PubMed] [Google Scholar]
  5. Liepnieks JJ, Zhang LQ, Benson MD. Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology 2010 ; 75 : 324–327. [CrossRef] [PubMed] [Google Scholar]
  6. Yazaki M, Mitsuhashi S, Tokuda T, et al. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007 ; 7 : 235–242. [CrossRef] [PubMed] [Google Scholar]
  7. Ihse E, Suhr OB, Hellman U, Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J Mol Med 2011 ; 89 : 171–180. [CrossRef] [PubMed] [Google Scholar]
  8. Coelho T, Maia LF, Martins da Silva A, et al. Tafamidis for transthyretin familial amyloid polyneuropathy a randomized, controlled trial. Neurology 2012 ; 79 : 785–792. [CrossRef] [PubMed] [Google Scholar]
  9. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001 ; 411 : 494–498. [CrossRef] [PubMed] [Google Scholar]
  10. Coelho T, Adams D, Silva A, et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. New Engl J Med 2013 ; 369 : 819–829. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.